ICCM IceCure Medical, Ltd. Profit After Tax

Corporate emblem and logo of IceCure Medical Ltd (ICCM)

IceCure Medical Ltd (ICCM) operating net income on GURU.Markets reflects a steady cash inflow from the sale of consumables, while -0.02 indicates the level of this metric. The business relies on cutting-edge developments in AI-driven cryoablation. However, patent protection and stringent medical certifications create significant barriers to entry for competitors in this niche.

Net Income: IceCure Medical (ICCM) for 07/04/2022 - 10/31/2026

Financial and market metric breakdowns for icecure-medical.com (ICCM)

- market value and analyst target forecast:
Stock Price IceCure Medical|ICCM - Price Target Chart
- market capitalization data:
Market Valuation IceCure Medical Ltd|ICCM - Enterprise Value
- issuer book value statistics:
Net Asset Value per Share IceCure Medical|ICCM - Company Net Assets|Market Capitalization to Book Value Ratio icecure-medical.com|ICCM - Cumulative Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Capital IceCure Medical Ltd|ICCM - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient IceCure Medical|ICCM - Company Aggregate Debts|Debt to Book Value IceCure Medical Ltd|ICCM - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings IceCure Medical|Quick Liquidity Indicator icecure-medical.com
- company profitability and valuation multiples indicators:
ICCM - Net Profit
Fundamental valuation:ICCM, IceCure Medical, Ltd.
Flagship merchandise of IceCure Medical, Ltd.

Investors must filter out speculative noise by assessing the actual net income of IceCure Medical Ltd (ICCM) against the expansion of traditional radiation therapy. Analyzing the company's cash profit allows for the verification of business margins and prevents overpaying for the asset at its peak yield, confirming the issuer's fundamental stability amid growing competition in the tumor cryoablation niche.

Key competitors

Dexcom CGM (DXCM) - Net Profit|Company Net Income Penumbra, Inc.|novanta.com - Profit After Tax|Net Profit HAE|INSP - Company Net Income|PROCEPT BioRobotics Inc - Net Income|Net Profit CONMED Inc. CNMD|PLSE: Net Income|inmodemd.com - Profit After Payment of Taxes|PMI: Net Profit|SRDX - Net Financial Result|SENS (Senseonics Holdings) - Net Profit|Net Income NeuroPace Medical (NPCE)|Net Income TCMD (Tactile Systems Technology)|SNWV (sanuwave.com) - Final Profit|Company Net Income Outset Medical OM|ELMD - Net Income|LENSAR, Inc - Net Profit|Company Net Income AVITA Medical Inc|PROF: Net Profit|Company Profit BDMD|EDAP (EDAP TMS SA) - Net Profit|Bovie Medical (APYX) - Net Financial Result|Net Profit LUNG|Net Income telabio.com TELA|Net Profit CTSO (CytoSorbents Corporation)|Net Profit sensushealthcare.com SRTS|ZYXI - Company Net Income|ECOR: Company Net Income|RBOT (vicarioussurgical.com) - Net Income|Inspira Technologies - Final Profit|ICU (SeaStar Medical Holding) - Net Profit|Company Net Income IRIDEX Corp. IRIX|Company Net Income Intelligent Bio Solutions (INBS)|beyondair.net (XAIR) - Annual Net Income|Profusa, Inc. - Net Income|Net Profit STRATA Skin Sciences Inc. SSKN|GlucoTrack - Net Profit|Net Financial Result NanoVibronix Inc. NAOV|Venus Concept (VERO) - Company Net Income|Profit After Tax NUWE (Nuwellis Inc)|Company Net Income Aethlon|Net Income TransEnterix (ASXC)|Net Profit AVGR|BSGM - Company Net Income|Company Net Income Cutera CUTR|KNW: Company Profit|NARI: Net Income|Nevro Medical - Profit After Payment of Taxes|RSLS: Net Profit|SILK - Net Financial Result